Greece · Delayed Price · Currency is EUR ATH:XYLEK Statistics
Total Valuation
ATH:XYLEK has a market cap or net worth of EUR 12.50 million. The enterprise value is 37.63 million.
| Market Cap | 12.50M |
| Enterprise Value | 37.63M |
Important Dates
The next estimated earnings date is Friday, June 26, 2026.
| Earnings Date | Jun 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ATH:XYLEK has 48.83 million shares outstanding.
| Current Share Class | 48.83M |
| Shares Outstanding | 48.83M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -6.76% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 38.86.
| PE Ratio | 38.86 |
| Forward PE | n/a |
| PS Ratio | 0.32 |
| PB Ratio | 0.87 |
| P/TBV Ratio | 0.88 |
| P/FCF Ratio | 7.16 |
| P/OCF Ratio | 5.91 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.51, with an EV/FCF ratio of 21.54.
| EV / Earnings | 130.18 |
| EV / Sales | 0.96 |
| EV / EBITDA | 17.51 |
| EV / EBIT | 26.87 |
| EV / FCF | 21.54 |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 1.83.
| Current Ratio | 1.35 |
| Quick Ratio | 0.69 |
| Debt / Equity | 1.83 |
| Debt / EBITDA | 12.20 |
| Debt / FCF | 15.01 |
| Interest Coverage | 0.83 |
Financial Efficiency
Return on equity (ROE) is 2.24% and return on invested capital (ROIC) is 3.22%.
| Return on Equity (ROE) | 2.24% |
| Return on Assets (ROA) | 1.83% |
| Return on Invested Capital (ROIC) | 3.22% |
| Return on Capital Employed (ROCE) | 4.76% |
| Weighted Average Cost of Capital (WACC) | 6.69% |
| Revenue Per Employee | 241,889 |
| Profits Per Employee | 1,784 |
| Employee Count | 162 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 2.21 |
Taxes
In the past 12 months, ATH:XYLEK has paid 29,485 in taxes.
| Income Tax | 29,485 |
| Effective Tax Rate | 9.26% |
Stock Price Statistics
The stock price has increased by +9.01% in the last 52 weeks. The beta is 0.78, so ATH:XYLEK's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | +9.01% |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 0.26 |
| Relative Strength Index (RSI) | 42.32 |
| Average Volume (20 Days) | 51,086 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ATH:XYLEK had revenue of EUR 39.19 million and earned 289,056 in profits. Earnings per share was 0.01.
| Revenue | 39.19M |
| Gross Profit | 9.45M |
| Operating Income | 1.40M |
| Pretax Income | 318,542 |
| Net Income | 289,056 |
| EBITDA | 1.86M |
| EBIT | 1.40M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 1.09 million in cash and 26.22 million in debt, with a net cash position of -25.13 million or -0.51 per share.
| Cash & Cash Equivalents | 1.09M |
| Total Debt | 26.22M |
| Net Cash | -25.13M |
| Net Cash Per Share | -0.51 |
| Equity (Book Value) | 14.30M |
| Book Value Per Share | 0.29 |
| Working Capital | 7.33M |
Cash Flow
In the last 12 months, operating cash flow was 2.12 million and capital expenditures -368,620, giving a free cash flow of 1.75 million.
| Operating Cash Flow | 2.12M |
| Capital Expenditures | -368,620 |
| Depreciation & Amortization | 461,761 |
| Net Borrowing | -1.30M |
| Free Cash Flow | 1.75M |
| FCF Per Share | 0.04 |
Margins
Gross margin is 24.12%, with operating and profit margins of 3.57% and 0.74%.
| Gross Margin | 24.12% |
| Operating Margin | 3.57% |
| Pretax Margin | 0.81% |
| Profit Margin | 0.74% |
| EBITDA Margin | 4.75% |
| EBIT Margin | 3.57% |
| FCF Margin | 4.46% |
Dividends & Yields
ATH:XYLEK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 2.31% |
| FCF Yield | 13.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ATH:XYLEK has an Altman Z-Score of 1.33 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.33 |
| Piotroski F-Score | 7 |